Summary:
Study to evaluate efficacy and safety of 2 doses of study drug add on to maitenance triple therapy in subjects with COPD and chronic bronchitis
Qualified Participants Must:
• Be 40 years old with a 12 month history of COPD and at least 1 moderate to severe COPD exacerbation in the last 12 months
Qualified Participants May Receive:
70.00 per visit and all services at no cost